VectivBio Holding AG (VECT) has a consensus analyst rating of Buy, based on 3 analysts covering the stock. Of those, 3 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for VECT is $18.00, representing a +6.7% upside from the current price of $16.87. Price targets range from a low of $18.00 to a high of $18.00.
